People: Furiex Pharmaceuticals Inc (FURX.O)
Mr. Robert P. Ruscher is Independent Director of Furiex Pharmaceuticals Inc. He has more than 20 years of experience working closely with emerging growth, technology-based companies (privately held/venture capital-backed and publicly traded), as well as the investors and investment banks that help finance them. Mr. Ruscher began his business career as a certified public accountant working with San Francisco Bay area technology companies for three years, which was followed by seven years as a corporate attorney representing primarily life science companies, including those focused in the fields of biotechnology and specialty pharmaceuticals. In 1995 Mr. Ruscher joined Salix Pharmaceuticals (a gastroenterology specialty pharmaceutical company) as Director, Business Development and advanced to positions of increasing responsibility, culminating in becoming President and Chief Executive Officer and a member of the Board of Directors in 1999. As President and Chief Executive Officer, Mr. Ruscher formulated and implemented Salix’s strategic change from a “virtual” model to a product-based sales and marketing focused specialty pharmaceutical company, including managing employee growth, overseeing a FDA New Drug Application approval process for Salix’s first product and receiving an FDA approvable letter for its second product. Mr. Ruscher served as President and Chief Executive Officer of Salix from 1999 to 2002, served as Executive Chairman of the Board from 2002 to 2003, and retired from Salix in 2005. Since that time he has been a private investor.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|